SEC Form 4 · accession 0001179110-17-001902
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph J Manning
Officer — Senior Vice President
Period of report
Feb 3, 2017
Accepted (ET)
Feb 7, 2017 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 3, 2017 | M | 300 | $25.2461 | A | 20,792 | D | |
| Common shares without par value | Feb 3, 2017 | F | 213 | $42.75 | D | 20,579 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $25.2461 | Feb 3, 2017 | M | 300 | D | Feb 16, 2010 | Feb 15, 2017 | Common shares | 300 | 0 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.